Replies to post #178422 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

As I understand the registration of the trial the schedule incorporates both the P2b and P3 stages of the trial.

Unfortunately there is no indication of the criteria for switching patients from P2a to P3, but perhaps at least some safety influences will announce at some midpoint.

If things are going really well with patients and caregivers noticing, perhaps that could lead to some press.